How hepatitis B affects inflammatory bowel disease
Part of Digestive system, Infections clinical trials.
This study looks at how hepatitis B virus affects people with inflammatory bowel disease (IBD). It may help doctors better understand the link between the two conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have been diagnosed with inflammatory bowel disease (like Crohn's disease or ulcerative colitis).
- You are willing to take part in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at how to diagnose Inflammatory Bowel Disease (IBD) in people who have just been diagnosed. It may help find better ways to detect and manage the condition.
This study looks at how common non-alcoholic fatty liver disease is in people with inflammatory bowel disease (Crohn's or colitis). Researchers want to learn more about the link between the two conditions.
This study looks at the bacteria in the gut of people with HIV or hepatitis B. You may be asked to provide a stool sample to help researchers understand how these infections affect your microbiome.
This study looks at the genes of people with chronic hepatitis B (HBV) to find why some people's immune cells (B cells and NK cells) stop working properly. The goal is to discover new ways to treat the disease.
This study looks at how the immune system changes over time in people with chronic hepatitis B. It will help doctors better understand the stages of the disease to guide treatment decisions.
This study looks at how treating chronic hepatitis B affects people's daily lives, not just their liver health. It aims to understand the good and bad impacts from a patient's perspective.
Hear when a new Inflammatory Bowel Disease (IBD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.